Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: Opportunities and challenges
Archives of Biochemistry and Biophysics · 2024
DOI: 10.1016/j.abb.2024.109994 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Biochemistry and Biophysics, 2024. Verfasst von Aghdas Ramezani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Imaging, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran. Electronic a…. Hauptthemen laut MEDLINE: Exosomes, Multiple Myeloma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 140 Literaturangaben.
Abstract (Originalsprache)
Interactions between the plasma cells and the BM microenvironment of Multiple myeloma (MM) take place through factors such as exosomes. Many studies have confirmed the role of exosomes in these interactions. By carrying proteins, cytokines, lipids, microRNAs, etc. as their cargo, exosomes can regulate the interactions between MM plasma cells and neighboring cells and participate in the signaling between cancer cells and the environment. It has been shown that MM-derived exosomes can induce angiogenesis, enhance osteoblast activity, confer drug resistance, and have immunosuppressive properties. Abnormal cargos in endosomes originating from MM patients, can be used as a cancer biomarker to detect or screen early prognosis in MM patients. The native nanostructure of exosomes, in addition to their biocompatibility, stability, and safety, make them excellent candidates for therapeutic, drug delivery, and immunomodulatory applications against MM. On the other hand, exosomes derived from dendritic cells (DC) may be used as vaccines against MM. Thanks to the development of new 'omics' approaches, we anticipate to hear more about exosomes in fight against MM. In the present review, we described the most current knowledge on the role of exosomes in MM pathogenesis and their potential role as novel biomarkers and therapeutic tools in MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Imaging, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran. Electronic address: Ramezani.ag@iums.ac.ir.
- Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: Tafazzoliaida74@gmail.com.
- Production Department, Carayakhteh Co (Ltd), Tehran, Iran. Electronic address: Salimi.f@carayakhteh.com.
- Department of Pathology, Dalhousie University, Halifax, NS, Canada; Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, NS, Canada. Electronic address: mh704089@dal.ca.
- Islamic Azad University, Ayatollah Amoli Branch, Amol, Iran. Electronic address: Hanie.arjmandi@gmail.com.
- Department of Research and Production of Poultry Viral Vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization, Karaj 3197619751, Iran. Electronic address: khalesi…
Zitieren
APA
Ramezani, A., Tafazoli, A., Salimi, F., Ghavami, M., Arjmandi, H., Khalesi, B., Hashemi, Z. S., & Khalili, S. (2024). Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: Opportunities and challenges. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2024.109994
Vancouver
Ramezani A, Tafazoli A, Salimi F, Ghavami M, Arjmandi H, Khalesi B, et al. Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: Opportunities and challenges. Archives of Biochemistry and Biophysics. 2024. doi:10.1016/j.abb.2024.109994
BibTeX
@article{Ramezani2024,
author = {Ramezani, Aghdas and Tafazoli, Aida and Salimi, Fatemeh and Ghavami, Mahlegha and Arjmandi, Hanie and Khalesi, Bahman and Hashemi, Zahra Sadat and Khalili, Saeed},
title = {Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: Opportunities and challenges},
journal = {Archives of Biochemistry and Biophysics},
year = {2024},
doi = {10.1016/j.abb.2024.109994}
}
EUVIMED